Point of Care Infectious Disease Testing Market Size, Trends & Growth Report by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Point of Care Infectious Disease Testing Market Size Analysis

Global Point of Care Infectious Disease Testing Market Introduction
By Product
1. Introduction
  1. Product By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Lateral Flow Immunoassay
  1. By Value
3. Agglutination Test
  1. By Value
4. Flow-through test/ Immunoconcentration Assay
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Respiratory Infection Testing Products
  1. By Value
  2. Influenza testing products
    1. Influenza testing products By Value
  3. Tuberculosis
    1. Tuberculosis By Value
  4. Other respiratory infection testing products
    1. Other respiratory infection testing products By Value
3. Healthcare-Associated Infection Testing Products
  1. By Value
4. Tropical Disease Testing Products
  1. By Value
5. Sexually Transmitted Disease Testing Products
  1. By Value
  2. HIV testing products
    1. HIV testing products By Value
  3. Hepatitis testing products
    1. Hepatitis testing products By Value
  4. Syphilis testing products
    1. Syphilis testing products By Value
  5. Human papillomavirus testing products
    1. Human papillomavirus testing products By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospital
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Home-care settings
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Lateral Flow Immunoassay
  1. By Value
3. Agglutination Test
  1. By Value
4. Flow-through test/ Immunoconcentration Assay
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Respiratory Infection Testing Products
  1. By Value
  2. Influenza testing products
    1. Influenza testing products By Value
  3. Tuberculosis
    1. Tuberculosis By Value
  4. Other respiratory infection testing products
    1. Other respiratory infection testing products By Value
3. Healthcare-Associated Infection Testing Products
  1. By Value
4. Tropical Disease Testing Products
  1. By Value
5. Sexually Transmitted Disease Testing Products
  1. By Value
  2. HIV testing products
    1. HIV testing products By Value
  3. Hepatitis testing products
    1. Hepatitis testing products By Value
  4. Syphilis testing products
    1. Syphilis testing products By Value
  5. Human papillomavirus testing products
    1. Human papillomavirus testing products By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospital
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Home-care settings
  1. By Value
5. Others
  1. By Value
U.S.
1. By Product
  1. Introduction
    1. Product By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Software and Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Lateral Flow Immunoassay
    1. By Value
  3. Agglutination Test
    1. By Value
  4. Flow-through test/ Immunoconcentration Assay
    1. By Value
  5. Molecular Diagnostics
    1. By Value
  6. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Respiratory Infection Testing Products
    1. By Value
    2. Influenza testing products
      1. Influenza testing products By Value
    3. Tuberculosis
      1. Tuberculosis By Value
    4. Other respiratory infection testing products
      1. Other respiratory infection testing products By Value
  3. Healthcare-Associated Infection Testing Products
    1. By Value
  4. Tropical Disease Testing Products
    1. By Value
  5. Sexually Transmitted Disease Testing Products
    1. By Value
    2. HIV testing products
      1. HIV testing products By Value
    3. Hepatitis testing products
      1. Hepatitis testing products By Value
    4. Syphilis testing products
      1. Syphilis testing products By Value
    5. Human papillomavirus testing products
      1. Human papillomavirus testing products By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospital
    1. By Value
  3. Diagnostic Laboratories
    1. By Value
  4. Home-care settings
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Lateral Flow Immunoassay
  1. By Value
3. Agglutination Test
  1. By Value
4. Flow-through test/ Immunoconcentration Assay
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Respiratory Infection Testing Products
  1. By Value
  2. Influenza testing products
    1. Influenza testing products By Value
  3. Tuberculosis
    1. Tuberculosis By Value
  4. Other respiratory infection testing products
    1. Other respiratory infection testing products By Value
3. Healthcare-Associated Infection Testing Products
  1. By Value
4. Tropical Disease Testing Products
  1. By Value
5. Sexually Transmitted Disease Testing Products
  1. By Value
  2. HIV testing products
    1. HIV testing products By Value
  3. Hepatitis testing products
    1. Hepatitis testing products By Value
  4. Syphilis testing products
    1. Syphilis testing products By Value
  5. Human papillomavirus testing products
    1. Human papillomavirus testing products By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospital
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Home-care settings
  1. By Value
5. Others
  1. By Value
U.K.
1. By Product
  1. Introduction
    1. Product By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Software and Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Lateral Flow Immunoassay
    1. By Value
  3. Agglutination Test
    1. By Value
  4. Flow-through test/ Immunoconcentration Assay
    1. By Value
  5. Molecular Diagnostics
    1. By Value
  6. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Respiratory Infection Testing Products
    1. By Value
    2. Influenza testing products
      1. Influenza testing products By Value
    3. Tuberculosis
      1. Tuberculosis By Value
    4. Other respiratory infection testing products
      1. Other respiratory infection testing products By Value
  3. Healthcare-Associated Infection Testing Products
    1. By Value
  4. Tropical Disease Testing Products
    1. By Value
  5. Sexually Transmitted Disease Testing Products
    1. By Value
    2. HIV testing products
      1. HIV testing products By Value
    3. Hepatitis testing products
      1. Hepatitis testing products By Value
    4. Syphilis testing products
      1. Syphilis testing products By Value
    5. Human papillomavirus testing products
      1. Human papillomavirus testing products By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospital
    1. By Value
  3. Diagnostic Laboratories
    1. By Value
  4. Home-care settings
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Lateral Flow Immunoassay
  1. By Value
3. Agglutination Test
  1. By Value
4. Flow-through test/ Immunoconcentration Assay
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Respiratory Infection Testing Products
  1. By Value
  2. Influenza testing products
    1. Influenza testing products By Value
  3. Tuberculosis
    1. Tuberculosis By Value
  4. Other respiratory infection testing products
    1. Other respiratory infection testing products By Value
3. Healthcare-Associated Infection Testing Products
  1. By Value
4. Tropical Disease Testing Products
  1. By Value
5. Sexually Transmitted Disease Testing Products
  1. By Value
  2. HIV testing products
    1. HIV testing products By Value
  3. Hepatitis testing products
    1. Hepatitis testing products By Value
  4. Syphilis testing products
    1. Syphilis testing products By Value
  5. Human papillomavirus testing products
    1. Human papillomavirus testing products By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospital
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Home-care settings
  1. By Value
5. Others
  1. By Value
China
1. By Product
  1. Introduction
    1. Product By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Software and Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Lateral Flow Immunoassay
    1. By Value
  3. Agglutination Test
    1. By Value
  4. Flow-through test/ Immunoconcentration Assay
    1. By Value
  5. Molecular Diagnostics
    1. By Value
  6. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Respiratory Infection Testing Products
    1. By Value
    2. Influenza testing products
      1. Influenza testing products By Value
    3. Tuberculosis
      1. Tuberculosis By Value
    4. Other respiratory infection testing products
      1. Other respiratory infection testing products By Value
  3. Healthcare-Associated Infection Testing Products
    1. By Value
  4. Tropical Disease Testing Products
    1. By Value
  5. Sexually Transmitted Disease Testing Products
    1. By Value
    2. HIV testing products
      1. HIV testing products By Value
    3. Hepatitis testing products
      1. Hepatitis testing products By Value
    4. Syphilis testing products
      1. Syphilis testing products By Value
    5. Human papillomavirus testing products
      1. Human papillomavirus testing products By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospital
    1. By Value
  3. Diagnostic Laboratories
    1. By Value
  4. Home-care settings
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Lateral Flow Immunoassay
  1. By Value
3. Agglutination Test
  1. By Value
4. Flow-through test/ Immunoconcentration Assay
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Respiratory Infection Testing Products
  1. By Value
  2. Influenza testing products
    1. Influenza testing products By Value
  3. Tuberculosis
    1. Tuberculosis By Value
  4. Other respiratory infection testing products
    1. Other respiratory infection testing products By Value
3. Healthcare-Associated Infection Testing Products
  1. By Value
4. Tropical Disease Testing Products
  1. By Value
5. Sexually Transmitted Disease Testing Products
  1. By Value
  2. HIV testing products
    1. HIV testing products By Value
  3. Hepatitis testing products
    1. Hepatitis testing products By Value
  4. Syphilis testing products
    1. Syphilis testing products By Value
  5. Human papillomavirus testing products
    1. Human papillomavirus testing products By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospital
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Home-care settings
  1. By Value
5. Others
  1. By Value
UAE
1. By Product
  1. Introduction
    1. Product By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Software and Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Lateral Flow Immunoassay
    1. By Value
  3. Agglutination Test
    1. By Value
  4. Flow-through test/ Immunoconcentration Assay
    1. By Value
  5. Molecular Diagnostics
    1. By Value
  6. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Respiratory Infection Testing Products
    1. By Value
    2. Influenza testing products
      1. Influenza testing products By Value
    3. Tuberculosis
      1. Tuberculosis By Value
    4. Other respiratory infection testing products
      1. Other respiratory infection testing products By Value
  3. Healthcare-Associated Infection Testing Products
    1. By Value
  4. Tropical Disease Testing Products
    1. By Value
  5. Sexually Transmitted Disease Testing Products
    1. By Value
    2. HIV testing products
      1. HIV testing products By Value
    3. Hepatitis testing products
      1. Hepatitis testing products By Value
    4. Syphilis testing products
      1. Syphilis testing products By Value
    5. Human papillomavirus testing products
      1. Human papillomavirus testing products By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospital
    1. By Value
  3. Diagnostic Laboratories
    1. By Value
  4. Home-care settings
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product
1. Introduction
  1. Product By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Software and Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Lateral Flow Immunoassay
  1. By Value
3. Agglutination Test
  1. By Value
4. Flow-through test/ Immunoconcentration Assay
  1. By Value
5. Molecular Diagnostics
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Respiratory Infection Testing Products
  1. By Value
  2. Influenza testing products
    1. Influenza testing products By Value
  3. Tuberculosis
    1. Tuberculosis By Value
  4. Other respiratory infection testing products
    1. Other respiratory infection testing products By Value
3. Healthcare-Associated Infection Testing Products
  1. By Value
4. Tropical Disease Testing Products
  1. By Value
5. Sexually Transmitted Disease Testing Products
  1. By Value
  2. HIV testing products
    1. HIV testing products By Value
  3. Hepatitis testing products
    1. Hepatitis testing products By Value
  4. Syphilis testing products
    1. Syphilis testing products By Value
  5. Human papillomavirus testing products
    1. Human papillomavirus testing products By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospital
  1. By Value
3. Diagnostic Laboratories
  1. By Value
4. Home-care settings
  1. By Value
5. Others
  1. By Value
Brazil
1. By Product
  1. Introduction
    1. Product By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Software and Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Lateral Flow Immunoassay
    1. By Value
  3. Agglutination Test
    1. By Value
  4. Flow-through test/ Immunoconcentration Assay
    1. By Value
  5. Molecular Diagnostics
    1. By Value
  6. Others
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Respiratory Infection Testing Products
    1. By Value
    2. Influenza testing products
      1. Influenza testing products By Value
    3. Tuberculosis
      1. Tuberculosis By Value
    4. Other respiratory infection testing products
      1. Other respiratory infection testing products By Value
  3. Healthcare-Associated Infection Testing Products
    1. By Value
  4. Tropical Disease Testing Products
    1. By Value
  5. Sexually Transmitted Disease Testing Products
    1. By Value
    2. HIV testing products
      1. HIV testing products By Value
    3. Hepatitis testing products
      1. Hepatitis testing products By Value
    4. Syphilis testing products
      1. Syphilis testing products By Value
    5. Human papillomavirus testing products
      1. Human papillomavirus testing products By Value
4. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospital
    1. By Value
  3. Diagnostic Laboratories
    1. By Value
  4. Home-care settings
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Point of Care Infectious Disease Testing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Abbott
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
BD
Chembio Diagnostics, Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics
Bio-Rad Laboratories, Inc.
BIOMÉRIEUX SA
Trivitron Healthcare
QuidelOrtho Corporation
Cepheid
Hologic, Inc
OraSure Technologies Inc.
EKF Diagnostics Holdings plc.
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment